The PARP-1 gene polymorphisms have been previously reported to be associated with risk in various carcinomas, including colon [13], lung cancer [14], bladder [15], prostate [16], head and neck [17], and breast cancer [18, 19]. Here, PARP1 is linked to breast carcinoma.